- Fecal Incontinence
Start date: 11/17/16 End date: 11/17/17
This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with irritable bowel syndrome (IBS).
After completing this program, participants should be better able to:
Describe approaches for assessing study design and safety, efficacy, and tolerability results for IBS/CIC therapies
Integrate data from randomized controlled trials (RCTs) with clinical experience to design evidence-based treatment plans for patients with IBS-C/CIC
Integrate data from RCTs with clinical experience to design evidence-based treatment plans for patients with IBS-D
Physician Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Gi Health Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Nursing Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. A maximum of 1.5 contact hours may be earned for a successful completion of this activity.
Americans with Disabilities Act
The event staff will be glad to assist you with any special needs (ie physical, dietary, etc.). Please contact us prior to the event at 1-877-782-4532. This event is neither sponsored by nor endorsed by ACG. Supported by educational grants from Allergan, Inc., Ironwood Pharmaceuticals, Inc., Salix Pharmaceuticals, and Synergy Pharmaceuticals.
For more information, email us at info@GiHealthFoundation.org, or call 1-877-782-4532.